Клаус Кёнлейн - Вирусомания

12 Fiala, Christian, Lie ben wir gefahrlich? Ein Arzt auf der Suche nach Fakten und Hintergruenden von AIDS, Deuticke, 1997, p. 202

13 Keou, Francois-Xavier, World Health Organization clinical case definition for AIDS in Africa: an analysis of evaluations, East African Medical Journal, October 1992, pp. 550 - 553

14 Lang, Serge, Challenges; Springer, New York, 1998, pp. 610 - 611

15 de Harven, Etienne, Of Mice And Men; Viral Etiology Of Human Cancer: A historical perspective, Continuum, Summer/Fall 2001

16 Mbeki, Thabo, A synthesis report of the deliberations by the panel of experts invited by the President of the Republic of South Africa, chapter 2.2. 1.: Visualisation and Isolation of the Virus, March 2001, see www.polity.org.za/html!govdocs/reports/aids/chapter2.htm#2.2.1

17 Tahi, Djamel, Did Luc Montagnier Discover HIV?, Interview mit Luc Montagnier, Continuum, Winter 1997/1998, pp. 31 - 35

18 de Harven, Etienne, Problems with isolating HIV, European Parliament in Brussels, 8 December 2003, see: www.altheal.org/texts/isolhiv.htm

19 Papadopulos-Eleopulos, Eleni; Turner, Valendar, A critique of the Montagnier evidence for the HIV/AIDS hypothesis, Medical Hypotheses, 4/2004, pp. 597 - 601

20 Structure of most deadly virus in the world revealed, press release, University of Oxford, 23 January 2006

21 Briggs, John, The Mechanism of HIV- 1 Core Assembly: Insights from Three Dimensional Reconstructions of Authentic Virions, Structure, January 2006, p. 16

22 Ibid., pp. 15 - 20

21 Structure of most deadly virus in the world revealed, press release, University of Oxford, 23 January 2006

24 Briggs, John, The Mechanism of HIV- 1 Core Assembly: Insights from Three Dimensional Reconstructions of Authentic Virions, Structure, January 2006, p. 19

25 Metzler, Natasha, Generic AZT Hits the United States, Pharmexec.com, 10 October 2005

26 Hodgkinson, Neville, How Giant Drug Firm Funds The AIDS Lobby, Sunday Times (London), 30 May 1993

27 Briggs, John, The Mechanism of H IV- 1 Core Assembly: Insights from Three Dimensional Reconstructions of Authentic Virions, Structure, January 2006, p. 16

28 Ibid.

29 Ibid.

30 Personal interview with Val Turner, 3 February 2006

31 Personal interview with StepeHIV Fuller; 10 February 2006

32 Gallo, Robert; Fauci Anthony, The human retroviruses, in: Fauci, Anthony, Harrison's Principles of Internal Medicine, McGraw-Hill, 1994, pp. 808 - 814

33 Papadoupulos-Eleopulos, Eleni; Turner, Valendar, The request reMayns the same and is still pure and simple, British Medical Journal (online), 12. June 2003, see http://www.rethinking.org/bmi/response _ 33236.hrml

34 HIV structure and Genome, Wikipedia-Website, see http://en.wikipedia.org/wiki/HIV _ structure _ and _ genome

35 Briggs, John, The Mechanism of HIV-1 Core Assembly: Insights from Three Dimensional Reconstructions of Authentic Virions, Structure, January 2006, p. 16 ■

36 Welker, Reinhold, Biochemical and Structural Analysis of Isolated Mature Cores of Human Immunodeficiency Virus Type 1, Journal of Virology, February 2000, pp. 1 168 - 1 177

37 Bess, Julyan, Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations, Virology, 31 March 1997, pp. 134 - 144

38 Gluschankof, Pablo, Cell membrane vesicles are a major contaminant of gradientenriched human immunodeficiency virus type- 1 preparations, Virology, 31 March 1997, pp. 125 - 133

39 Hackenbroch, Veronika, "Der Optimism us ist verflogen." Der Virologe, AIDS-Forscher und Leiter des Berliner Robert Koch Instituts, Reinhard Kurth, i.iber die ersten HIV-Impfstoff-Tests in Deutschland, Der Spiegel, 9/2004, p. 153

40 Tahi, Djamel, AIDS-die grossen Zweifel, Arte Television, 14 March 1996, see www.torstenengelbrecht.corn/de/artikel _ medien.html

41 Papadopulos-Eleopulos, Eleni; Turner, Valendar, A critique of the Montagnier evidence for the HIV/AIDS hypothesis, Medical Hypotheses, 4!2004, p. 584

42 Barre-Sinoussi, Francoise; Cherman, Jean Claude, Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS, Lancet, 7 April 1984; pp. 753 - 757

43 Macilwain, Colin, AAAS criticized over AIDS sceptics' meeting, Nature, 26 May 1994, p. 265

44 Lang, Serge, Challenges; Springer, New York, 1998, p. 609

45 Berger, Michael; Muehlhauser, Ingrid, Surrogatmarker: Trugschlüsse, Deutsches Arzteblatt, 6 December 1996, pp. A-3280-A3283

46 ELISA Test-kit from Abbot Laboratories

47 Papadopulos-Eleopulos, Eleni; Turner, Valendar, Is a Positive Western Blot Proof of HIV Infection?, Nature BiotecHIVology, June 1993, p p . 696 - 707

48 Gli.icksspiel AIDS-Test, Die Woche, 5 August 1993, see www.AIDS-info.net/michaihiv/AIDS/diewoche _ 1.html

49 Papadopulos-Eleopulos, Eleni; Turner, Valendar, The Isolation of HIV-Has It Really Been Achieved? The Case Against, Continuum, September/October 1996, Supplement, pp. 1 - 24

50 Gli.icksspiel AIDS-Test, Die Woche, 5 August 1993, see

www.AIDS-info.net/micha/hiv/AIDS/diewochel.html

51 Essex, Max; Kashala, Oscar, Infection with human immonodificiency virus type 1 (hiv- 1 ) and human t-cell lymphotropic viruses among leprosy patients and contacts: correlation between hiv- 1 cross-reactivity and antibodies to lipoarabinomanna; Journal of Infectious Diseases, February 1994, pp. 296 - 304

52 Johnson, Christine, Whose Antibodies are they anyway?, Continuum, September/October 1996, pp. 4 - 5

53 Hodgkinson, Neville, H N diagnosis: a ludicrous case of circular reasoning, The Business online, 16 May 2004

54 Duesberg, Peter; KoeHIVlein, Claus; Rasnick, David, The Chemical Bases of the Various AIDS Epidemics: Recreational Drugs, Anti-viral Chemotherapy and Malnutrition, Journal of Biosciences, June 2003, p. 390

55 Hackenbroch, Veronika, "Der Optimism us ist verflogen." Der Virologe, AIDS-Forscher und Leiter des Berliner Robert Koch Instituts, Reinhard Kurth, iiber die ersten HIV-Impfstoff-Tests in Deutschland, Der Spiegel, 9/2004, p. 153

56 Papadopulos-Eleopulos, Eleni; Turner, Valendar, HIV antibody tests and viral load-more unanswered questions and a further plea for clarification, Current Medical Research and Opinion, 3/1998, pp. 185 - 186

57 Rich, Josiah, Misdiagnosis of HIV infection by HIV- 1 plasma viral load testing: a case series, Annals of Internal Medicine, 5 January 1999, pp. 37 - 39

58 Rodriguez, Benigno, Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection, Journal of the American Medical Association, 27 September 2006, pp. 1498 - 1506

59 Papadopulos-Eleopulos, Eleni; Turner, Valendar, A critical analysis of the HIV-T4-cell-AIDS hypothesis, Genetica, 1 - 3/1995; pp. 5 - 24

60 Epstein, Steven, Impure Science-AIDS, Activism and the Politics of Knowledge, University of California Press, 1996, pp. 75, 109

61 Concorde Coordinating Committee, Concorde: MRCC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV-infection, Lancet, 9 April 1994, 343: 871 - 881

62 Fleming, Thomas; DeMets, David, Surrogate end points in clinical trials: are we being misled?, Annals of Internal Medicine, 1 October 1996, pp. 605 - 613

63 Williams, Brian, HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations, Journal of Infectious Diseases, 15 November 2006, pp. 1450 - 1458

64 Chargaff, Erwin, Das Feuer des Heraklit, Luchterhand, 1989, p. 232

65 Lichtblau, Eric, Settlement in Marketing of a Drug for AIDS, New York Times, 18 October 2005

66 Duesberg, Peter; KoeHIVlein, Claus; Rasnick, David, The Chemical Bases of the Various AIDS Epidemics: Recreational Drugs, Anti-viral Chemotherapy and Malnutrition, Journal of Riosciences, June 2003, pp. 383 - 412